TY - JOUR
T1 - Use of liposomes as drug delivery vehicles for treatment of melanoma
AU - Tran, Melissa A.
AU - Watts, Rebecca J.
AU - Robertson, Gavin P.
N1 - Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 2009/8
Y1 - 2009/8
N2 - Melanoma is a progressive disease that claims many lives each year due to lack of therapeutics effective for the long-term treatment of patients. Currently, the best treatment option is early detection followed by surgical removal. Better melanoma therapies that are effectively delivered to tumors with minimal toxicity for patients are urgently needed. Nanotechnologies provide one approach to encapsulate therapeutic agents leading to improvements in circulation time, enhanced tumor uptake, avoidance of the reticulo-endothelial system, and minimization of toxicity. Liposomes in particular are a promising nanotechnology that can be used for more effective delivery of therapeutic agents to treat melanoma. Liposomes delivering chemotherapies, siRNA, asODNs, DNA, and radioactive particles are just some of the promising new nanotechnology based therapies under development for the treatment of melanoma that are discussed in this review.
AB - Melanoma is a progressive disease that claims many lives each year due to lack of therapeutics effective for the long-term treatment of patients. Currently, the best treatment option is early detection followed by surgical removal. Better melanoma therapies that are effectively delivered to tumors with minimal toxicity for patients are urgently needed. Nanotechnologies provide one approach to encapsulate therapeutic agents leading to improvements in circulation time, enhanced tumor uptake, avoidance of the reticulo-endothelial system, and minimization of toxicity. Liposomes in particular are a promising nanotechnology that can be used for more effective delivery of therapeutic agents to treat melanoma. Liposomes delivering chemotherapies, siRNA, asODNs, DNA, and radioactive particles are just some of the promising new nanotechnology based therapies under development for the treatment of melanoma that are discussed in this review.
UR - http://www.scopus.com/inward/record.url?scp=67749135874&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67749135874&partnerID=8YFLogxK
U2 - 10.1111/j.1755-148X.2009.00581.x
DO - 10.1111/j.1755-148X.2009.00581.x
M3 - Review article
C2 - 19493316
AN - SCOPUS:67749135874
VL - 22
SP - 388
EP - 399
JO - Pigment Cell and Melanoma Research
JF - Pigment Cell and Melanoma Research
SN - 1755-1471
IS - 4
ER -